Inactive

Primer Capital

General contacts
Investor type

PE / VC

Founded

2015

AUM

-

Location

Moscow, Moscow, Russia

Investment Ticket

$1-5 m

Investment Stage

Series A Seed Series B

Region of investment

Europe
Investor profile last updated: 30 August, 2026

Profile

Primer Capital is a private equity firm based in Moscow, Russia, founded in 2015. The firm has a team of 8 people, including 3 partners. Primer Capital distinguishes itself by focusing on investments in the biotechnology and pharmaceutical sectors, particularly in companies developing medical products.

The firm primarily invests in the biotechnology, clinical trials, and pharmaceutical sectors. Primer Capital participates in various investment stages, including Series A and Series B rounds. They have a flexible investment approach, co-investing with other firms like Two Sigma Ventures. The firm does not specify a typical check size or total assets under management.

Notable investments by Primer Capital include Acticor Biotech - a company that went public, Mindera Health - a health diagnostics company, and Nelo - a financial services company. They have also invested in Botkin.AI, a company specializing in AI-driven medical diagnostics.

Industry

Pharmaceuticals Medical Devices Biotechnology

Contacts

Name
Title
Email
Social Networks
avatar
Anton Lavrentev CEO
CEO
a•••@•••
LinkedIn
avatar
Olga Tsyuryupa Investment Director
Investment Director
o•••@•••
LinkedIn
Upgrade to see contacts
avatar
aW4NnPQEzkxDS0sJ aW4NnPQEzkxDS0sJ
aW4NnPQEzkxDS0sJ
[email protected]
linkedin twitter
avatar
aW4NnPQEzkxDS0sJ aW4NnPQEzkxDS0sJ
aW4NnPQEzkxDS0sJ
[email protected]
linkedin twitter
avatar
aW4NnPQEzkxDS0sJ aW4NnPQEzkxDS0sJ
aW4NnPQEzkxDS0sJ
[email protected]
linkedin twitter
Investment-team contacts for Primer Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Primer Capital

Primer Capital is a venture capital and private equity firm. It backs companies at Series A, Seed and Series B, writing tickets of $1-5 m.
Primer Capital is located in Moscow, Moscow, Russia.
Primer Capital was founded in 2015.
Primer Capital invests in companies and startups in Pharmaceuticals, Medical Devices, Biotechnology.
Primer Capital invests in companies and startups in Europe.
Primer Capital invests in companies and startups at Series A, Seed, Series B.
Primer Capital usually invests $1-5 m on average.
Primer Capital can be reached through its website primer-capital.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Primer Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Primer Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 30 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.